Weight & metabolism
Modern GLP-1 molecules investigated in global studies of metabolic health.
Metabolizmus5-Amino-1MQ
Selective NNMT inhibitor. A small organic molecule (not a peptide) blocking Nicotinamide N-Methyltransferase — preclinically increases the NAD+ and SAM pool and promotes adipocyte thermogenesis.
- ● ≥ 99 %
- ● CoA
- ● EU stock
57,90 € Detail- New
MetabolizmusCagrilintide
Long-acting amylin analog. Lead component of the CagriSema combination regimen in Phase 3.
- ● ≥ 99 %
- ● CoA
- ● EU stock
86,90 € Detail - New
MetabolizmusRetatrutide
Triple GIP / GLP-1 / glucagon agonist. The third generation of metabolic peptides in active clinical investigation.
- ● ≥ 99 %
- ● CoA
- ● EU stock
97,90 € Detail
